Metrion Biosciences is Drug Discovery in United Kingdom that focus on safety profiling assays business. They cover business area such as operator, (CRO, ion channel drug discovery service, highly skilled electrophysiology screen service, flexible business model, each program, option, integrate drug discovery service, client, medicinal chemistry optimization program.
-
Safety Profiling Assays
-
Suite 1, Riverside 3
Granta Park, Great Abington
Cambridge CB21 6AD
England, United Kingdom
Private
operator(CROion channel drug discovery servicehighly skilled electrophysiology screen serviceflexible business modeleach programoptionintegrate drug discovery serviceclientmedicinal chemistry optimization program
* We use standard office opening hours in near Metrion Biosciences's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Metrion Biosciences is Drug Discovery business from United Kingdom that founded in - ( years old in ), Metrion Biosciences business is focusing on Safety Profiling Assays.
Metrion Biosciences headquarter office and corporate office address is located in Suite 1, Riverside 3 Granta Park, Great Abington Cambridge CB21 6AD England, United Kingdom.
Metrion Biosciences was founded in United Kingdom.
In , Metrion Biosciences is currently focus on safety profiling assays sector.
Above is snippet of Google Trends for "safety profiling assays" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Metrion Biosciences, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
